Freeze-all cycles for normal responders: Is this way forward?

Background: The freeze-all approach has gained traction in in vitro fertilization (IVF) practices, and this study explores its benefits for normal responders. Aims and Objectives: The study evaluates whether the freeze-all strategy is advantageous in normal responders, irrespective of ovarian respon...

Full description

Saved in:
Bibliographic Details
Main Authors: Satish Sharma, Shalaka Mhatre, Ashwini Jadhav, Nikita Lad
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-12-01
Series:MGM Journal of Medical Sciences
Subjects:
Online Access:https://doi.org/10.4103/mgmj.mgmj_172_24
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: The freeze-all approach has gained traction in in vitro fertilization (IVF) practices, and this study explores its benefits for normal responders. Aims and Objectives: The study evaluates whether the freeze-all strategy is advantageous in normal responders, irrespective of ovarian response. Materials and Methods: A retrospective study was conducted at a private IVF center, analyzing 225 oocyte retrieval cases and 170 frozen embryo transfers performed between January 2023 and February 2024. All patients underwent controlled ovarian stimulation using a gonadotropin-releasing hormone antagonist regimen, with the freeze-all policy applied. Fresh embryo transfers were postponed, and all embryos were cryopreserved. Frozen–thawed embryo transfers (FET) were performed in subsequent cycles. Results: The implantation rate for cleavage-stage FETs was 13.79%, whereas for blastocyst-stage transfers, it was 31.61%. The clinical pregnancy rate was 43.75% for cleavage-stage and 47.40% for blastocyst-stage FETs. Conclusion: The freeze-all approach can enhance IVF outcomes. However, an individualized treatment plan is essential for optimizing results, as there are currently no noninvasive clinical methods to determine, which patients would benefit most from a freeze-all strategy.
ISSN:2347-7946
2347-7962